PuSH - Publikationsserver des Helmholtz Zentrums München

Khalin, I.* ; Severi, C.* ; Heimburger, D.* ; Wehn, A.* ; Hellal, F. ; Reisch, A.* ; Klymchenko, A.S.* ; Plesnila, N.*

Dynamic tracing using ultra-bright labelling and multi-photon microscopy identifies endothelial uptake of poloxamer 188 coated poly(lactic-co-glycolic acid) nano-carriers in vivo.

Nanomed. 40:102511 (2022)
Postprint DOI PMC
Open Access Green
The potential of poly(lactic-co-glycolic acid) (PLGA) to design nanoparticles (NPs) and target the central nervous system remains to be exploited. In the current study we designed fluorescent 70-nm PLGA NPs, loaded with bulky fluorophores, thereby making them significantly brighter than quantum dots in single-particle fluorescence measurements. The high brightness of NPs enabled their visualization by intravital real-time 2-photon microscopy. Subsequently, we found that PLGA NPs coated with pluronic F-68 circulated in the blood substantially longer than uncoated NPs and were taken up by cerebro-vascular endothelial cells. Additionally, confocal microscopy revealed that coated PLGA NPs were present in late endothelial endosomes of cerebral vessels within 1hour after systemic injection and were more readily taken up by endothelial cells in peripheral organs. The combination of ultra-bright NPs and in vivo imaging may thus represent a promising approach to reduce the gap between development and clinical application of nanoparticle-based drug carriers.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Blood–brain Barrier ; Bulky Counterion ; Nanocarriers ; Pluronic F68 ; Poly(lactic-co-glycolic Acid)
ISSN (print) / ISBN 1743-5889
e-ISSN 1748-6963
Zeitschrift Nanomedicine
Quellenangaben Band: 40, Heft: , Seiten: , Artikelnummer: 102511 Supplement: ,
Verlag Future Medicine
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute for Tissue Engineering and Regenerative Medicine (ITERM)
Förderungen Horizon 2020
Deutsche Forschungsgemeinschaft
European Research Council
Alexander von Humboldt-Stiftung
Marie Skłodowska-Curie
ERA-NET Neuron TRAINS
Agence National de Recherche JC/JC